|1.||Borggrefe, Martin: 2 articles (01/2007 - 07/2003)|
|2.||Dempfle, Carl-Erik: 2 articles (01/2007 - 07/2003)|
|3.||Morrissey, J H: 2 articles (12/2000 - 10/2000)|
|4.||Bauer, K A: 2 articles (12/2000 - 09/2000)|
|5.||Miller, G J: 2 articles (12/2000 - 10/2000)|
|6.||Rosenberg, R D: 2 articles (12/2000 - 09/2000)|
|7.||Babiker, A M: 1 article (07/2014)|
|8.||Ehab, A M: 1 article (07/2014)|
|9.||Fathelrahman, M H: 1 article (07/2014)|
|10.||Li, Xiaokun: 1 article (05/2014)|
|1.||Disseminated Intravascular Coagulation
01/01/2001 - "Plasmas from patients suffering from disseminated intravascular coagulation demonstrate very large crosslinked FnDP fragments in their plasmas which seem to contain not alone fibrinopeptide A but also subunits with intact alpha chains. "
05/01/1986 - "Concentrations of plasma fibrinopeptide A (FPA) were measured by radioimmunoassay in 50 patients with venous thromboembolism or disseminated intravascular coagulation or both. "
10/15/1990 - "The in vivo efficacy of rTAP was demonstrated using a model of low grade disseminated intravascular coagulation where the purified inhibitor was shown to significantly inhibit thromboplastin-induced fibrinopeptide A generation following an infusion into conscious rhesus monkeys. "
12/28/1990 - "Platelet numbers did not correlate with fibrinopeptide A or fibrin split product levels suggesting that disseminated intravascular coagulation or fibrinolysis may have had less influence on platelet numbers than certain other factors. "
12/17/1985 - "Urinary fibrinopeptide A immunoreactivity was determined by radioimmunoassay using two anti-fibrinopeptide A sera with a different specificity in patients with venous thromboembolism, disseminated intravascular coagulation and rheumatoid arthritis. "
11/24/1986 - "[Fibrinopeptide A in patients with diabetes mellitus complicated by angiopathy]."
09/01/1985 - "Fibrinopeptide-A in diabetes mellitus. "
01/01/1985 - "Beta-thromboglobulin and fibrinopeptide A in diabetes mellitus as markers of vascular damage."
03/01/1984 - "Plasma beta-thromboglobulin, platelet factor 4, fibrinopeptide A, and other hemostatic functions during improved, short-term glycemic control in diabetes mellitus."
07/01/1985 - "To determine the relationship between thrombin generation and platelet secretion in vivo in diabetes mellitus, we measured simultaneous plasma beta-thromboglobulin (BTG) and fibrinopeptide A (FPA) in 40 insulin-dependent patients without renal disease, and 20 control subjects of similar age. "
|3.||Intracranial Thrombosis (Cerebral Thrombosis)
01/01/2002 - "In patients with acute cerebral thrombosis, neuronal symptoms improved significantly compared with the placebo group, wherein activated partial thromboplastin time (aPTT) was prolonged by about 1.5-fold and fibrinopeptide A was reduced. "
12/01/1990 - "In cerebral thrombosis, fibrinogen and fibrinopeptide A levels were elevated significantly in all stages (p less than 0.001), whereas plasmin-alpha 2 plasmin inhibitor complex and D dimer levels were elevated significantly in the subacute and chronic periods. "
12/01/1990 - "We assayed plasma concentrations of fibrinogen, fibrinopeptide A, plasmin-alpha 2 plasmin inhibitor complex, D dimer, and antithrombin III activity in 40 patients with cerebral thrombosis and nine patients with cerebral embolism during the acute (less than 7 days), subacute (7-27 days), and chronic (greater than or equal to 28 days) periods and compared these with 69 controls. "
09/01/1987 - "In 19 patients with acute myocardial infarction fibrinopeptide A was elevated to 82.3 +/- 43.5 ng/ml (mean +/- SE) before therapy. "
01/01/1979 - "Fibrinopeptide a (FPA) in patients with acute myocardial infarction."
01/01/1989 - "Fibrinopeptide A (FPA) levels were determined in 40 consecutive patients admitted to the coronary care unit with a typical history of chest pain: in 24 of them a diagnosis of acute myocardial infarction (AMI) and in 16 a diagnosis of angina was made. "
02/01/1981 - "In 98 patients with ischemic heart disease (IHD), independent of their clinical status (previous myocardial infarction, spontaneous angina or effort angina), a hypercoagulable state (indicated by significant elevation of fibrinopeptide A plasma level) and an increased platelet biologic activity were observed. "
03/01/1992 - "Plasma fibrinopeptide A levels in patients with acute myocardial infarction treated with alteplase. "
05/01/1996 - "Patients with unstable angina pectoris and abnormal fibrinopeptide A plasma levels are at increased risk for an early unfavorable outcome."
05/01/1996 - "Plasma concentrations and 24-hour urinary excretion of fibrinopeptide A were prospectively determined in 150 patients with unstable angina. "
09/03/1991 - "The largest increase in plasma and urine concentration of fibrinopeptide A was observed in patients whose first episode of angina at rest occurred within the previous 48 hours. "
09/03/1991 - "Twenty-four-hour urine excretion of fibrinopeptide A in patients with unstable angina and angiographically documented intracoronary thrombi were higher than the corresponding values in patients with unstable angina without such angiographic characteristic (p less than 0.001). "
09/03/1991 - "The concentrations of fibrinopeptide A in the plasma did not differ significantly when patients with stable angina (range 0.1 to 82.6, median 7.4 ng/mL) were compared with patients with unstable angina (range 0.2 to 61.7, median 14 ng/mL, p = 0.055), whereas fibrinopeptide A 24-hour urinary excretion was significantly higher in patients with unstable angina (range 0.3 to 38.1, median 11.8 micrograms/24 hr) than in patients with stable angina (range 0.4 to 38.1, median 3.8 micrograms/24 hr, p less than 0.001). "
|2.||Fibrinogen (Factor I)
|3.||Platelet Factor 4
|5.||Thromboplastin (Tissue Factor)
|8.||Prothrombin (Factor II)
|9.||Tissue Plasminogen Activator (Alteplase)
|1.||Drug Therapy (Chemotherapy)
|5.||Cardiopulmonary Bypass (Heart-Lung Bypass)